Gene expression patterns associated with p53 status in breast cancer. - Wikidata - wikimedia - TriplyDB

Gene expression patterns associated with p53 status in breast cancer.

Gene expression patterns associated with p53 status in breast cancer.

http://www.wikidata.org/entity/Q33265626

about

Understanding and treating triple-negative breast cancer Comprehensive molecular portraits of human breast tumours The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer RNAi-mediated knock-down of arylamine N-acetyltransferase-1 expression induces E-cadherin up-regulation and cell-cell contact growth inhibition Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system Differential pathogenesis of lung adenocarcinoma subtypes involving sequence mutations, copy number, chromosomal instability, and methylation A compact VEGF signature associated with distant metastases and poor outcomes.Current data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based?Expression signatures of TP53 mutations in serous ovarian cancers.Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX Contribution of p53 to metastasis.Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures.Unraveling the regulatory connections between two controllers of breast cancer cell fate Do two machine-learning based prognostic signatures for breast cancer capture the same biological processes?Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivation.Mitochondrial Hep27 is a c-Myb target gene that inhibits Mdm2 and stabilizes p53.Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer.Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin Triple Negative Breast Cancer - An Overview Treatment options for patients with triple-negative breast cancer Targeting breast cancer stem cells.Stem cell-like gene expression in ovarian cancer predicts type II subtype and prognosis Novel neoadjuvant therapy paradigms for bladder cancer: results from the National Cancer Center Institute Forum.Overexpression of miR-146a in basal-like breast cancer cells confers enhanced tumorigenic potential in association with altered p53 status Characterization of the p53 cistrome--DNA binding cooperativity dissects p53's tumor suppressor functions.Comparison and identification of estrogen-receptor related gene expression profiles in breast cancer of different ethnic origins Identification of potential synthetic lethal genes to p53 using a computational biology approach Can systems biology understand pathway activation? Gene expression signatures as surrogate markers for understanding the complexity of pathway activation.An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer.Pathologic progression of mammary carcinomas in a C3(1)/SV40 T/t-antigen transgenic rat model of human triple-negative and Her2-positive breast cancer.Genomic analyses across six cancer types identify basal-like breast cancer as a unique molecular entity.Effects of TP53 mutational status on gene expression patterns across 10 human cancer types.Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value Triple-Negative Breast Cancer: Clinical and Histological Correlations.Gene expression analysis of in vitro cocultures to study interactions between breast epithelium and stroma.Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).p53, a target of estrogen receptor (ER) α, modulates DNA damage-induced growth suppression in ER-positive breast cancer cells.Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline- or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial.Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy.p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.

P2860

Q24620957-3317BE60-F310-4DF8-B601-D4C79B5DE28E Q24630844-3F956FBE-0FBC-4B71-A6FF-1F37296F532C Q28468629-C36B491F-A5C5-450F-BE97-A9BBABDADCF3 Q28477123-049410E5-2D85-4830-B4B6-E0E91C3BBF16 Q28484040-D4A22B59-80CE-439A-B323-F9531F1056DB Q28730029-3C40193A-09D1-4865-93E9-7F3226AEE8E9 Q33418745-1790DFC6-B54B-4552-878E-6865DB7E77F9 Q33500786-F46FDE5E-93A6-45E3-85DE-67A324FDB789 Q33588196-0CFF55DC-077F-4F30-BFB7-4D8A198AF90B Q33739357-60029E64-1BBE-4FF4-9CFD-0A8E8E860946 Q33776331-6E07E282-C575-4729-93C7-EF68BB0FCBD5 Q33788520-7DE5D092-C543-4392-BE0D-E85317D71A2D Q33791223-38B6CBEC-D991-4B26-91F8-0CDBB4ABF529 Q33851661-4BAB40D4-111A-407A-925B-2C053966C49F Q33865095-E19B7155-8825-4D55-844B-64F4F9CAA5FC Q34045740-E83D30B4-E06E-4E7D-BA7C-B54B5018F5FE Q34058510-4AF0ED80-8DB9-4C18-917C-61CCAC577163 Q34123261-A15171BA-7262-4FDB-8D50-FF3154DF5B35 Q34274285-DD16748C-7965-4D0F-99F3-D2C463C1435D Q34331406-E49D5B68-8570-442C-AA24-3974E5416C88 Q34505105-A9FF8D10-E035-4C89-87CF-5CDEF9FA3194 Q34639023-E4EEC2A5-6E3F-48D4-B200-9130B5EC1E02 Q34670535-EF2D53BA-D17F-49D2-8E5E-55A480993001 Q34882515-13016D5B-F7EC-4112-AEF5-92C4CD191B09 Q34961997-6CCA33E4-55F9-4ED3-8B5A-66BBA127BCEF Q34965545-EE3BCE09-B204-4905-85C7-65931E2D6BD0 Q34985284-7DAEA9AF-0C68-4447-A904-88ADDCC1A2E1 Q34986181-3889C2C9-4212-4DFB-904D-E15F7011B0D1 Q34989075-4004C597-C8D0-4129-839C-B966D2AB82EA Q35010102-344782FD-8FAC-472F-9869-2FD951DA9CDC Q35079683-775024A6-3217-43AD-9D33-D4C51846DCD7 Q35185345-6F751B56-158A-41DD-84F0-E0D0E5C0512B Q35503492-F8A3743C-91C9-4B22-A780-DC5C28DE6D70 Q35576252-D6D10992-B835-4CCC-BF92-AF45B3C60EB8 Q35616195-4A682158-5436-4881-9428-BB9F0F105766 Q35904572-AED779DF-7BD6-4296-925C-0EF916967ADC Q36216301-BC8B9C64-C78C-4039-BFEE-A98D9467FD9E Q36245341-8E85A72E-1443-4831-8ECC-6F69766B5D8A Q36383626-EE036CA0-57EE-4006-A00B-2EED042261EB Q36507886-442ACA2C-EEED-4823-963A-C03810933F6F

P2860

Gene expression patterns associated with p53 status in breast cancer.

http://www.wikidata.org/entity/Q33265626

description

2006 nî lūn-bûn

@nan

2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Gene expression patterns associated with p53 status in breast cancer.

@ast

Gene expression patterns associated with p53 status in breast cancer.

@en

type

label

Gene expression patterns associated with p53 status in breast cancer.

@ast

Gene expression patterns associated with p53 status in breast cancer.

@en

prefLabel

Gene expression patterns associated with p53 status in breast cancer.

@ast

Gene expression patterns associated with p53 status in breast cancer.

@en

P1433

Q33265626-1E5A5828-1F92-4A04-BF3A-9BF40A953783

P1476

Q33265626-CEAA2046-3FD4-4F86-8B28-302571EAAB4E

P2093

Q33265626-6A83D9D0-8C8B-4E93-A3F0-870C8AE0ED69

Q33265626-9D5BBC13-4AD2-4345-AB3D-87D7C967A3B0

Q33265626-B2B06803-EB54-4AC4-BA23-3F664636BCE8

Q33265626-DC60E078-A8EF-4F9E-9470-C5167114B637

Q33265626-E9D88DAA-E58D-48B3-9F8D-712ACAA2E177

P2860

Q33265626-0073DAD4-52A7-405E-AD91-E3698E0E2468

Q33265626-0732DFDB-72DC-4D19-B6CF-4EF13E7F75ED

Q33265626-0AECF8F0-5B1F-46C9-B986-2A3F5D05162F

Q33265626-113ECE17-6C23-4703-A32F-2851EBD93E01

Q33265626-186EF243-CDCF-45B7-B18D-AB11BE054942

Q33265626-1BDCC508-CDFC-4BC4-B630-28746EF57642

Q33265626-23DFFBDD-2E2D-4F9E-A062-3701597288C1

Q33265626-4B215F26-8966-4DF5-A3D0-EC53C6E91661

Q33265626-55DDF3B7-DA7D-4274-8E93-4D5AD34C672A

Q33265626-59B998C0-4E7B-4C40-8AF8-FEA7255780E0

P2888

Q33265626-A4FC748B-C892-4176-B28B-F5DD133A2CF1

P304

Q33265626-BFA6C5D2-8F57-4D73-B48E-31B675061AF6

P31

Q33265626-F52F6EBE-4689-499D-B268-B4C47A30582D

P356

Q33265626-987ADEC0-AA1A-42E0-976E-7031E5FFB545

P407

Q33265626-633C49EB-2D3E-4466-9597-B070F157DB32

P478

Q33265626-E05CF20A-BB22-4573-B2C4-F8FA45F226B2

P50

Q33265626-67E618FA-AE89-406B-A634-FF8F8895C2F5

Q33265626-6AA61FA8-7DB9-47FA-9688-AA81A5E50A62

P577

Q33265626-6CA6D6D4-6032-490E-8761-F065E10CF6FC

P5875

Q33265626-D4119D8B-F1FE-48FD-944E-C210C4796ED2

P6179

Q33265626-BBD21E23-299C-4738-BDDD-9109161DBC44

P698

Q33265626-817307A8-5BE1-4867-93C6-053A013A6ED0

P932

Q33265626-E9D3ABD6-779E-4594-921D-CD7C8614E561

P356

1471-2407-6-276

P1433

P1476

Gene expression patterns associated with p53 status in breast cancer

@en

P2093

Claire S Barbier

http://www.w3.org/2001/XMLSchema#string

Daniel S Oh

http://www.w3.org/2001/XMLSchema#string

Jason I Herschkowitz

http://www.w3.org/2001/XMLSchema#string

Melissa A Troester

http://www.w3.org/2001/XMLSchema#string

Xiaping He

http://www.w3.org/2001/XMLSchema#string

P2860

A model for p53-induced apoptosis

NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription

Significance analysis of microarrays applied to the ionizing radiation response

Identifying biological themes within lists of genes with EASE

Cluster analysis and display of genome-wide expression patterns

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Gene expression profiling predicts clinical outcome of breast cancer

A system for stable expression of short interfering RNAs in mammalian cells

Molecular portraits of human breast tumours

Repeated observation of breast tumor subtypes in independent gene expression data sets

P2888

1471-2407-6-276

P304

276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-6-276

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Charles M. Perou

Katherine A Hoadley

P577

2006-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6649489

http://www.w3.org/2001/XMLSchema#string

P6179

1039833406

http://www.w3.org/2001/XMLSchema#string

P698

17150101

http://www.w3.org/2001/XMLSchema#string

P932

1764759

http://www.w3.org/2001/XMLSchema#string